Shopping Cart 0
Cart Subtotal
AED 0

Acromegaly Global Clinical Trials Review, H2, 2019

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 9175

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 18350

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 27525

Details

Acromegaly Global Clinical Trials Review, H2, 2019

Summary

GlobalData's clinical trial report, Acromegaly Global Clinical Trials Review, H2, 2019" provides an overview of Acromegaly clinical trials scenario. This report provides top line data relating to the clinical trials on Acromegaly . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

READ MORE

Table Of Content

Scope

Table of Contents

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Top Countries Contributing to Clinical Trials in Middle East and Africa 14

Top Five Countries Contributing to Clinical Trials in Central and South America 15

Clinical Trials by G7 Countries: Proportion of Acromegaly to Hormonal Disorders Clinical Trials 16

Clinical Trials by Phase in G7 Countries 18

Clinical Trials in G7 Countries by Trial Status 19

Clinical Trials by E7 Countries: Proportion of Acromegaly to Hormonal Disorders Clinical Trials 21

Clinical Trials by Phase in E7 Countries 23

Clinical Trials in E7 Countries by Trial Status 24

Clinical Trials by Phase 26

In Progress Trials by Phase 27

Clinical Trials by Trial Status 28

Clinical Trials by End Point Status 30

Subjects Recruited Over a Period of Time 31

Clinical Trials by Sponsor Type 32

Prominent Sponsors 33

Top Companies Participating in Acromegaly Therapeutics Clinical Trials 35

Prominent Drugs 37

Clinical Trial Profile Snapshots 38

Appendix 162

Abbreviations 162

Definitions 162

Research Methodology 163

Secondary Research 163

About GlobalData 164

Contact Us 164

Source 165


List Of Figure

List of Figures

Acromegaly Therapeutics, Global, Clinical Trials by Region (%), 2019* 7

Acromegaly Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 8

Acromegaly Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10

Acromegaly Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 11

Acromegaly Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 12

Acromegaly Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 13

Acromegaly Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2019* 14

Acromegaly Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 15

Proportion of Acromegaly to Hormonal Disorders Clinical Trials, G7 Countries (%), 2019* 16

Acromegaly Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18

Acromegaly Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19

Proportion of Acromegaly to Hormonal Disorders Clinical Trials, E7 Countries (%), 2019* 21

Acromegaly Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 23

Acromegaly Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 24

Acromegaly Therapeutics, Global, Clinical Trials by Phase (%), 2019* 26

Acromegaly Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 27

Acromegaly Therapeutics, Global, Clinical Trials by Trial Status, 2019* 28

Acromegaly Therapeutics Clinical Trials, Global, by End Point Status, 2019* 30

Acromegaly Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 31

Acromegaly Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 32

Acromegaly Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 33

Acromegaly Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 35

Acromegaly Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 37

GlobalData Methodology 163


List Of Table

List of Tables

Acromegaly Therapeutics, Global, Clinical Trials by Region, 2019* 7

Acromegaly Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9

Acromegaly Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10

Acromegaly Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 11

Acromegaly Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 12

Acromegaly Therapeutics Clinical Trials, North America, Top Countries, 2019* 13

Acromegaly Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2019* 14

Acromegaly Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 15

Proportion of Acromegaly to Hormonal Disorders Clinical Trials, G7 Countries (%), 2019* 17

Acromegaly Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18

Acromegaly Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20

Proportion of Acromegaly to Hormonal Disorders Clinical Trials, E7 Countries (%), 2019* 22

Acromegaly Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 23

Acromegaly Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 25

Acromegaly Therapeutics, Global, Clinical Trials by Phase, 2019* 26

Acromegaly Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 27

Acromegaly Therapeutics, Global, Clinical Trials by Trial Status, 2019* 29

Acromegaly Therapeutics Clinical Trials, Global, by End Point Status, 2019* 30

Acromegaly Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 31

Acromegaly Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 32

Acromegaly Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 34

Acromegaly Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 36

Acromegaly Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 37

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Ipsen SA

Novartis AG

Pfizer Inc

Chiasma Inc

Sandberg Development AB

Accelsiors CRO & Consultancy Services

Crinetics Pharmaceuticals Inc

Midatech Pharma Plc

Antisense Therapeutics Ltd

Aspireo Pharmaceuticals Ltd

Company Profile

Company Profile Title

Acromegaly Global Clinical Trials Review, H2, 2019

Summary

GlobalData's clinical trial report, Acromegaly Global Clinical Trials Review, H2, 2019" provides an overview of Acromegaly clinical trials scenario. This report provides top line data relating to the clinical trials on Acromegaly . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

READ MORE

Scope

Table of Contents

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Top Countries Contributing to Clinical Trials in Middle East and Africa 14

Top Five Countries Contributing to Clinical Trials in Central and South America 15

Clinical Trials by G7 Countries: Proportion of Acromegaly to Hormonal Disorders Clinical Trials 16

Clinical Trials by Phase in G7 Countries 18

Clinical Trials in G7 Countries by Trial Status 19

Clinical Trials by E7 Countries: Proportion of Acromegaly to Hormonal Disorders Clinical Trials 21

Clinical Trials by Phase in E7 Countries 23

Clinical Trials in E7 Countries by Trial Status 24

Clinical Trials by Phase 26

In Progress Trials by Phase 27

Clinical Trials by Trial Status 28

Clinical Trials by End Point Status 30

Subjects Recruited Over a Period of Time 31

Clinical Trials by Sponsor Type 32

Prominent Sponsors 33

Top Companies Participating in Acromegaly Therapeutics Clinical Trials 35

Prominent Drugs 37

Clinical Trial Profile Snapshots 38

Appendix 162

Abbreviations 162

Definitions 162

Research Methodology 163

Secondary Research 163

About GlobalData 164

Contact Us 164

Source 165


List Of Figure

List of Figures

Acromegaly Therapeutics, Global, Clinical Trials by Region (%), 2019* 7

Acromegaly Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 8

Acromegaly Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10

Acromegaly Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 11

Acromegaly Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 12

Acromegaly Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 13

Acromegaly Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2019* 14

Acromegaly Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 15

Proportion of Acromegaly to Hormonal Disorders Clinical Trials, G7 Countries (%), 2019* 16

Acromegaly Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18

Acromegaly Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19

Proportion of Acromegaly to Hormonal Disorders Clinical Trials, E7 Countries (%), 2019* 21

Acromegaly Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 23

Acromegaly Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 24

Acromegaly Therapeutics, Global, Clinical Trials by Phase (%), 2019* 26

Acromegaly Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 27

Acromegaly Therapeutics, Global, Clinical Trials by Trial Status, 2019* 28

Acromegaly Therapeutics Clinical Trials, Global, by End Point Status, 2019* 30

Acromegaly Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 31

Acromegaly Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 32

Acromegaly Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 33

Acromegaly Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 35

Acromegaly Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 37

GlobalData Methodology 163


List Of Table

List of Tables

Acromegaly Therapeutics, Global, Clinical Trials by Region, 2019* 7

Acromegaly Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9

Acromegaly Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10

Acromegaly Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 11

Acromegaly Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 12

Acromegaly Therapeutics Clinical Trials, North America, Top Countries, 2019* 13

Acromegaly Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2019* 14

Acromegaly Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 15

Proportion of Acromegaly to Hormonal Disorders Clinical Trials, G7 Countries (%), 2019* 17

Acromegaly Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18

Acromegaly Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20

Proportion of Acromegaly to Hormonal Disorders Clinical Trials, E7 Countries (%), 2019* 22

Acromegaly Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 23

Acromegaly Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 25

Acromegaly Therapeutics, Global, Clinical Trials by Phase, 2019* 26

Acromegaly Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 27

Acromegaly Therapeutics, Global, Clinical Trials by Trial Status, 2019* 29

Acromegaly Therapeutics Clinical Trials, Global, by End Point Status, 2019* 30

Acromegaly Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 31

Acromegaly Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 32

Acromegaly Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 34

Acromegaly Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 36

Acromegaly Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 37

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Ipsen SA

Novartis AG

Pfizer Inc

Chiasma Inc

Sandberg Development AB

Accelsiors CRO & Consultancy Services

Crinetics Pharmaceuticals Inc

Midatech Pharma Plc

Antisense Therapeutics Ltd

Aspireo Pharmaceuticals Ltd